Yeah, I hope Kyocera kills it with their scale-up technology. I think one of the pivotal questions here is how quickly the treatment will be scaled. If the rate is 10,000 patients in year 1, and then (totally arbitrarily) say 50,000, in year 2 and 2, 200,000 in year 3, then it could be quite...